Daniela Matei

  • 7535 Citations
  • 44 h-Index
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Article

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Moore, K. N., Secord, A. A., Geller, M. A., Miller, D. S., Cloven, N., Fleming, G. F., Wahner Hendrickson, A. E., Azodi, M., DiSilvestro, P., Oza, A. M., Cristea, M., Berek, J. S., Chan, J. K., Rimel, B. J., Matei, D. E., Li, Y., Sun, K., Luptakova, K., Matulonis, U. A. & Monk, B. J., May 2019, In : The lancet oncology. 20, 5, p. 636-648 13 p.

Research output: Contribution to journalArticle

39 Scopus citations

N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients

Alley, W. R., Vasseur, J. A., Goetz, J. A., Svoboda, M., Mann, B. F., Matei, D. E., Menning, N., Hussein, A., Mechref, Y. & Novotny, M. V., Apr 6 2012, In : Journal of Proteome Research. 11, 4, p. 2282-2300 19 p.

Research output: Contribution to journalArticle

126 Scopus citations

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy

Matulonis, U. A., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Fielding, A., Spencer, S., Parry, D., Grinsted, L. & Ledermann, J. A., Jun 15 2016, In : Cancer. 122, 12, p. 1844-1852 9 p.

Research output: Contribution to journalArticle

44 Scopus citations

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C. L., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Fielding, A., Spencer, S., Dougherty, B., Orr, M., Hodgson, D., Barrett, J. C. & Matulonis, U., Jul 2014, In : The Lancet Oncology. 15, 8, p. 852-861 10 p.

Research output: Contribution to journalArticle

770 Scopus citations

Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer

Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Macpherson, E., Watkins, C., Carmichael, J. & Matulonis, U., Apr 12 2012, In : New England Journal of Medicine. 366, 15, p. 1382-1392 11 p.

Research output: Contribution to journalArticle

949 Scopus citations

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

Ledermann, J. A., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Fielding, A., Spencer, S., Rowe, P., Lowe, E., Hodgson, D., Sovak, M. A. & Matulonis, U., Nov 1 2016, In : The lancet oncology. 17, 11, p. 1579-1589 11 p.

Research output: Contribution to journalArticle

198 Scopus citations

PDGF BB induces VEGF secretion in ovarian cancer

Matei, D., Kelich, S., Cao, L., Menning, N., Emerson, R. E., Rao, J., Meei, H. J. & Sledge, G. W., Dec 2007, In : Cancer Biology and Therapy. 6, 12, p. 1951-1959 9 p.

Research output: Contribution to journalArticle

Open Access
47 Scopus citations

PDGF induced microRNA alterations in cancer cells

Shao, M., Rossi, S., Chelladurai, B., Shimizu, M., Ntukogu, O., Ivan, M., Calin, G. A. & Matei, D., May 1 2011, In : Nucleic acids research. 39, 10, p. 4035-4047 13 p.

Research output: Contribution to journalArticle

30 Scopus citations

Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028

Varga, A., Piha-Paul, S., Ott, P. A., Mehnert, J. M., Berton-Rigaud, D., Morosky, A., Yang, P., Ruman, J. & Matei, D., Feb 2019, In : Gynecologic oncology. 152, 2, p. 243-250 8 p.

Research output: Contribution to journalArticle

30 Scopus citations

Periostin secreted by epithelial ovarian carcinoma is a ligand for αVβ3 and αVβ5 integrins and promotes cell motility

Gillan, L., Matei, D., Fishman, D. A., Gerbin, C. S., Karlan, B. Y. & Chang, D. D., Sep 15 2002, In : Cancer Research. 62, 18, p. 5358-5364 7 p.

Research output: Contribution to journalArticle

424 Scopus citations

Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer

Vergote, I., Finkler, N., del Campo, J., Lohr, A., Hunter, J., Matei, D., Kavanagh, J., Vermorken, J. B., Meng, L., Jones, M., Brown, G. & Kaye, S., Sep 1 2009, In : European Journal of Cancer. 45, 13, p. 2324-2332 9 p.

Research output: Contribution to journalArticle

86 Scopus citations

Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

De Geest, K., Blessing, J. A., Morris, R. T., Yamada, S. D., Monk, B. J., Zweizig, S. L., Matei, D., Muller, C. Y. & Richards, W. E., Jan 1 2010, In : Journal of Clinical Oncology. 28, 1, p. 149-153 5 p.

Research output: Contribution to journalArticle

53 Scopus citations

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study

Fleming, G. F., Brunetto, V. L., Cella, D., Look, K. Y., Reid, G. C., Munkarah, A. R., Kline, R., Burger, R. A., Goodman, A. K., Burks, R. T. & Matei, D. E., Dec 1 2004, In : Women's Oncology Review. 4, 4, p. 287-289 3 p.

Research output: Contribution to journalArticle

Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)

Dhani, N. C., Hirte, H. W., Wang, L., Burnier, J. V., Jain, A., Butler, M. O., Welch, S., Fleming, G. F., Hurteau, J., Matsuo, K., Matei, D., Jimenez, W., Johnston, C., Cristea, M., Tonkin, K., Ghatage, P., Lheureux, S., Mehta, A., Quintos, J., Tan, Q. & 5 others, Kamel-Reid, S., Ludkovski, O., Tsao, M. S., Wright, J. J. & Oza, A. M., Jun 1 2020, In : Clinical Cancer Research. 26, 11, p. 2477-2486 10 p.

Research output: Contribution to journalArticle

1 Scopus citations

Platelet-derived growth factor pathway inhibitors in ovarian cancer

Schmitt, J. & Matei, D., Dec 2008, In : Clinical Ovarian Cancer. 1, 2, p. 120-126 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Postoperative radiation therapy for endometrial cancer: American society of clinical oncology clinical practice guideline endorsement of the American society for radiation oncology evidence-based guideline

Meyer, L. A., Bohlke, K., Powell, M. A., Fader, A. N., Franklin, G. E., Lee, L. J., Matei, D., Coallier, L. & Wright, A. A., Jan 1 2015, In : Journal of Clinical Oncology. 33, 26, p. 2908-2913 6 p.

Research output: Contribution to journalArticle

54 Scopus citations

Preclinical and clinical evaluation of 5‐fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with colorectal carcinoma

Matei, D., Hagag, N., Madajewicz, S., Chowhan, N., Hentschel, P., Avvento, L., Burns, P., Fiore, J., Lipera, W. & Zarrabi, H., Oct 15 1995, In : Cancer. 76, 8, p. 1330-1335 6 p.

Research output: Contribution to journalArticle

11 Scopus citations

Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity

Özeş, A. R., Pulliam, N., Ertosun, M. G., Yllmaz, Ö., Tang, J., Çopuroǧlu, E., Matei, D., Özeş, O. N. & Nephew, K. P., Jun 1 2018, In : Oncogene. 37, 26, p. 3589-3600 12 p.

Research output: Contribution to journalArticle

5 Scopus citations

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer

Ledermann, J. A., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Fielding, A., Bennett, B., Parry, D., Spencer, S., Mann, H. & Matulonis, U., Nov 22 2016, In : British Journal of Cancer. 115, 11, p. 1313-1320 8 p.

Research output: Contribution to journalArticle

28 Scopus citations

Ridaforolimus as a single agent in advanced endometrial cancer: Results of a single-arm, phase 2 trial

Colombo, N., McMeekin, D. S., Schwartz, P. E., Sessa, C., Gehrig, P. A., Holloway, R., Braly, P., Matei, D., Morosky, A., Dodion, P. F., Einstein, M. H. & Haluska, F., Mar 19 2013, In : British Journal of Cancer. 108, 5, p. 1021-1026 6 p.

Research output: Contribution to journalArticle

78 Scopus citations

Significance of number of positive lymph nodes and size as prognostic factors of recurrence and overall survival in cervical cancer patients

Attiah, D. G., Helenowski, I., Refaat, T., Strauss, J. B., Shahabi, S., Lurain, J., Pineda, M., Nieves-Neira, W., Matei, D. & Donnelly, E. D., Jan 1 2019, In : European Journal of Gynaecological Oncology. 40, 4, p. 609-613 5 p.

Research output: Contribution to journalArticle

SiRNA Delivery Using Dithiocarbamate-Anchored Oligonucleotides on Gold Nanorods

Wang, J., Thomas, M., Lin, P., Cheng, J. X., Matei, D. E. & Wei, A., Feb 20 2019, In : Bioconjugate Chemistry. 30, 2, p. 443-453 11 p.

Research output: Contribution to journalArticle

5 Scopus citations

Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction

Yakubov, B., Chen, L., Belkin, A. M., Zhang, S., Chelladurai, B., Zhang, Z. Y. & Matei, D., Feb 20 2014, In : PloS one. 9, 2, e89285.

Research output: Contribution to journalArticle

22 Scopus citations

Small molecules target the interaction between tissue transglutaminase and fibronectin

Sima, L. E., Yakubov, B., Zhang, S., Condello, S., Grigorescu, A. A., Nwani, N. G., Chen, L., Schiltz, G. E., Arvanitis, C., Zhang, Z. Y. & Matei, D., Jan 1 2019, In : Molecular cancer therapeutics. 18, 6, p. 1057-1068 12 p.

Research output: Contribution to journalArticle

Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group

Ramasubbaiah, R., Perkins, S. M., Schilder, J., Whalen, C., Johnson, C. S., Callahan, M., Jones, T., Sutton, G. & Matei, D., Dec 1 2011, In : Gynecologic oncology. 123, 3, p. 499-504 6 p.

Research output: Contribution to journalArticle

44 Scopus citations

Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase

Khanna, M., Chelladurai, B., Gavini, A., Li, L., Shao, M., Courtney, D., Turchi, J. J., Matei, D. & Meroueh, S., Apr 1 2011, In : Molecular cancer therapeutics. 10, 4, p. 626-636 11 p.

Research output: Contribution to journalArticle

24 Scopus citations

Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer

Shao, M., Hollar, S., Chambliss, D., Schmitt, J., Emerson, R., Chelladurai, B., Perkins, S., Ivan, M. & Matei, D., Jul 1 2012, In : Molecular cancer therapeutics. 11, 7, p. 1576-1586 11 p.

Research output: Contribution to journalArticle

24 Scopus citations

TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells

Cardenas, H., Vieth, E., Lee, J., Segar, M., Liu, Y., Nephew, K. P. & Matei, D., Dec 18 2014, In : Epigenetics. 9, 11, p. 1461-1472 12 p.

Research output: Contribution to journalArticle

71 Scopus citations

The Clinical Impact of Cancer Stem Cells

Lathia, J., Liu, H. & Matei, D., Feb 1 2020, In : Oncologist. 25, 2, p. 123-131 9 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer

Fang, F., Munck, J., Tang, J., Taverna, P., Wang, Y., Miller, D. F. B., Pilrose, J., Choy, G., Azab, M., Pawelczak, K. S., VanderVere-Carozza, P., Wagner, M., Lyons, J., Matei, D., Turchi, J. J. & Nephew, K. P., Dec 15 2014, In : Clinical Cancer Research. 20, 24, p. 6504-6516 13 p.

Research output: Contribution to journalArticle

58 Scopus citations

The platelet-derived growth factor receptor α is destabilized by geldanamycins in cancer cells

Matei, D., Satpathy, M., Cao, L., Lai, Y. C., Nakshatri, H. & Donner, D. B., Jan 5 2007, In : Journal of Biological Chemistry. 282, 1, p. 445-453 9 p.

Research output: Contribution to journalArticle

54 Scopus citations

Tissue tranglutaminase regulates interactions between ovarian cancer stem cells and the tumor niche

Condello, S., Sima, L., Ivan, C., Cardenas, H., Schiltz, G., Mishra, R. K. & Matei, D., Jun 1 2018, In : Cancer Research. 78, 11, p. 2990-3001 12 p.

Research output: Contribution to journalArticle

11 Scopus citations

Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer

Lee, J., Yakubov, B., Ivan, C., Jones, D. R., Caperell-Grant, A., Fishel, M., Cardenas, H. & Matei, D., Jan 1 2016, In : Neoplasia (United States). 18, 11, p. 689-698 10 p.

Research output: Contribution to journalArticle

11 Scopus citations

Tissue transglutaminase links TGF-Β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer

Cao, L., Shao, M., Schilder, J., Guise, T., Mohammad, K. S. & Matei, D., May 17 2012, In : Oncogene. 31, 20, p. 2521-2534 14 p.

Research output: Contribution to journalArticle

128 Scopus citations

Tissue transglutaminase mediated tumor-stroma interaction promotes pancreatic cancer progression

Lee, J., Condello, S., Yakubov, B., Emerson, R., Caperell-Grant, A., Hitomi, K., Xie, J. & Matei, D., Oct 1 2015, In : Clinical Cancer Research. 21, 19, p. 4482-4493 12 p.

Research output: Contribution to journalArticle

35 Scopus citations
74 Scopus citations

Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity

Satpathy, M., Shao, M., Emerson, R., Donner, D. B. & Matei, D., Jun 5 2009, In : Journal of Biological Chemistry. 284, 23, p. 15390-15399 10 p.

Research output: Contribution to journalArticle

50 Scopus citations

Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism

Condello, S., Cao, L. & Matei, D., Aug 1 2013, In : FASEB Journal. 27, 8, p. 3100-3112 13 p.

Research output: Contribution to journalArticle

27 Scopus citations

Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer

de Leon, M., Cardenas, H., Vieth, E., Emerson, R., Segar, M., Liu, Y., Nephew, K. & Matei, D., Sep 1 2016, In : Gynecologic oncology. 142, 3, p. 539-547 9 p.

Research output: Contribution to journalArticle

16 Scopus citations
16 Scopus citations

β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids

Condello, S., Morgan, C. A., Nagdas, S., Cao, L., Turek, J., Hurley, T. D. & Matei, D., Apr 30 2015, In : Oncogene. 34, 18, p. 2297-2308 12 p.

Research output: Contribution to journalArticle

88 Scopus citations